InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Tuesday, 03/02/2010 5:27:46 PM

Tuesday, March 02, 2010 5:27:46 PM

Post# of 295
4:27PM Nektar Therapeutics misses by $0.13 (NKTR) 12.53 -0.24 : Reports Q4 (Dec) ($0.08), $0.13 worse than the First Call consensus of $0.05; revenues rose 37.3% year/year to $39.0 mln vs the $51.4 mln consensus. Co said, "The decrease in revenue year over year is largely the result of lower contract research and manufacturing revenues primarily resulting from the sale of certain of the co's pulmonary assets to Novartis which occurred on December 31, 2008."


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTR News